Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Graft-versus-host Disease
• Hodgkin Lymphoma
• Myelodysplastic Myeloproliferative Neoplasm
• Myelogenous Leukemia Bcr-abl1 Positive
• Non-hodgkin Lymphoma
• Plasma Cell Myeloma
• Waldenstrom Macroglobulinemia

Drugs mentioned

• Lymphocyte infusion
• Pentostatin (pentostatin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-05-04